Nicotine Absorption Profile Among Regular Users of a Pod-Based Electronic Nicotine Delivery System
Open Access
- 1 November 2019
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1915494
Abstract
JUUL is a popular electronic nicotine delivery system (ENDS)1 that contains a liquid with a high nicotine concentration (59 mg/mL). While there are concerns about the rapid increase in use of this potentially addictive product,2 there are no independent published data, to our knowledge, on its blood nicotine absorption profile. This case series aimed to characterize nicotine absorption among regular adult users of this product and to evaluate subjective effects associated with use.Keywords
This publication has 6 references indexed in Scilit:
- Nicotine absorption during electronic cigarette use among regular usersPLOS ONE, 2019
- Adolescents’ Use of “Pod Mod” E-Cigarettes — Urgent ConcernsNew England Journal of Medicine, 2018
- Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette marketTobacco Control, 2018
- Nicotine delivery to users from cigarettes and from different types of e-cigarettesPsychopharmacology, 2017
- Nicotine delivery, retention and pharmacokinetics from various electronic cigarettesAddiction, 2015
- Development of a Questionnaire for Assessing Dependence on Electronic Cigarettes Among a Large Sample of Ex-Smoking E-cigarette UsersNicotine & Tobacco Research, 2014